Feasibility of Chemohyperthermia with Docetaxel-Embedded Magnetoliposomes as Minimally Invasive Local Treatment for Cancer

Department of Organ Regenerative Surgery, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Japan.
International Journal of Cancer (Impact Factor: 5.09). 01/2009; 126(8):1955-65. DOI: 10.1002/ijc.24864
Source: PubMed


Hyperthermia is a minimally invasive approach to cancer treatment, but it is difficult to heat only the tumor without damaging surrounding tissue. To solve this problem, we studied the effectiveness of chemohyperthermia with docetaxel-embedded magnetoliposomes (DMLs) and an applied alternating current (AC) magnetic field. Human MKN45 gastric cancer cells were implanted in the hind limb of Balb-c/nu/nu mice. Various concentrations of docetaxel-embedded DMLs were injected into the tumors and exposed to an AC magnetic field (n = 6, each). For comparison with hyperthermia alone, magnetite-loaded liposome (ML)-injected tumors were exposed to an AC magnetic field. Furthermore, the results of DML without AC treatment and docetaxel diluted into PBS with AC treatment were also compared (n = 10, each). Tumor surface temperature was maintained between 42 and 43 degrees C. Tumor volume was reduced in the DML group with a docetaxel concentration > 56.8 microg/ml, while a docetaxel concentration > 568.5 microg/ml was required for tumor reduction without hyperthermia. Statistically significant differences in tumor volume and survival rate were observed between the DML group exposed to the magnetic field and the other groups. The tumor disappeared in 3 mice in the DML group exposed to the magnetic field; 2 mice survived over 6 months after treatment, whereas all mice of the other groups died by 15 weeks. Histologically, hyperthermia with DML damaged tumor cells and DML diffused homogeneously. To the best of our knowledge, this is the first report to show that hyperthermia using chemotherapeutic agent-embedded magnetoliposomes has an anticancer effect.

Download full-text


Available from: Atsushi Horiuchi, Mar 12, 2014
25 Reads
  • Source
    • "There were also attempts to explore other types of liposomes for treating GI cancer to enhance tumor specific drug delivery.79,80 Injecting docetaxel embedded magnetoliposomes into human MKN45 gastric cancer bearing mice, followed by exposure to an alternating current or magnetic field and local hyperthermia, produced positive results where the amount of drug required for inhibiting cancer growth was greatly reduced, the size of the tumor was decreased, and the survival time was prolonged.79 Ultrasound was also utilized to trigger cisplatin release from sterically stabilized liposomes and almost 70% of liposomal cisplatin was released in tumor tissue, resulting in tumor regression.80 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the past decade, liposomes became a focal point in developing drug delivery systems. New liposomes, with novel lipid molecules or conjugates, and new formulations opened possibilities for safely and efficiently treating many diseases including cancers. New types of liposomes can prolong circulation time or specifically deliver drugs to therapeutic targets. This article concentrates on current developments in liposome based drug delivery systems for treating diseases of the gastrointestinal tract. We will review different types and uses of liposomes in the development of therapeutics for gastrointestinal diseases including inflammatory bowel diseases and colorectal cancer.
    International Journal of Nanomedicine 04/2013; 8:1325-34. DOI:10.2147/IJN.S42153 · 4.38 Impact Factor
  • Source
    • "To provide additional improvements to the nanoparticle aided delivery methodology, facilitated drug release and treatment visualization, some experimental systems have coencapsulated metallic nanoparticles alongside chemotherapeutic agents. This coencapsulation paradigm allows metallic nanoparticles to act as agents for imaging and controlled release of chemotherapeutics through their energy absorbing properties [100] [101] [122] [123] [124]. Moreover, the delivery of metallic nanoparticles and chemotherapeutic agents simultaneously provide an approximated visualization of drug delivery localization and treatment area [125-129]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To overcome problems of systemic toxicity associated with chemotherapy and enhance treatment resolution of cancer therapies, nanotechnology is increasingly providing many novel approaches, especially to energy-based cancer therapies. Enhancements to treatment targeting, the ability to facilitate combined therapies, and treatment imaging are but a few of the ongoing investigations in this ever growing field. This review briefly explores the modalities of energy-based cancer therapies, how nanotechnology has been allowed for improvements within them, and discusses potential future applications of combined therapies.
    American Journal of Cancer Research 01/2011; 1(4):508-20. · 4.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The heat generation ability of needle-type materials was studied for the application of thermal coagulation therapy in an AC magnetic field. Although the Ti tube without the MgFe2O4 powder or Ti rod showed poor heat generation abilities in an AC magnetic field, the temperature was significantly increased by the presence of ferrite powder in the Ti tube. We confirmed using a computer simulation that the eddy loss of the Ti tube was increased by the enhanced magnetic flux density due to the ferrite powder in the Ti tube. The heat generation of the ferrite filled Ti tube was increased by utilization of the quenched MgFe2O4 powder from elevated temperature. The relative magnetic permeability of the quenched ferrite was enhanced with the decrease in the inverse ratio of the cubic spinel structure. The heat generation ability was increased with the increase in the relative magnetic permeability of the Ti tube with ferrite powder. The calculated joule loss based on the experimental results showed an agreement with those using the computer simulation.
    Journal of Magnetism and Magnetic Materials 01/2011; 323(1):88-93. DOI:10.1016/j.jmmm.2010.08.035 · 1.97 Impact Factor
Show more